Ankle-brachial index as a marker of cognitive impairment and dementia in general population. A systematic review

Atherosclerosis

Volumn 216, Issue 2, 2011, Pages 251-257

  Guerchet, Maëlenn ^a   Aboyans, Victor ^a,b   Nubukpo, Philippe ^a   Lacroix, Philippe ^a,b   Clément, Jean Pierre ^a,b   Preux, Pierre Marie ^a,b  

^a UNIVERSITY OF LIMOGES   (France)

^b LIMOGES UNIVERSITY HOSPITAL   (France)

Author keywords

Ankle brachial index; Cognitive impairment; Dementia; Peripheral artery disease

Indexed keywords

ALZHEIMER DISEASE; ANKLE BRACHIAL INDEX; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; COGNITION; COGNITIVE DEFECT; COST; DEMENTIA; DISEASE PREDISPOSITION; HUMAN; LONGITUDINAL STUDY; MINI MENTAL STATE EXAMINATION; MULTIINFARCT DEMENTIA; PATIENT SAFETY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW;

AGED; ALZHEIMER DISEASE; ANKLE BRACHIAL INDEX; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; DEMENTIA; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PROSPECTIVE STUDIES; QUALITY CONTROL; RISK FACTORS;

EID: 79957976729     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.03.024     Document Type: Review

References (43)

1. Aboyans V., Criqui M.H. The epidemiology of peripheral arterial disease. Peripheral arterial disease 2009, 1-25. McGraw Hill. D. Robert (Ed.).
2. Ferri C.P., Prince M., Brayne C., et al. Alzheimer's disease international. Global prevalence of dementia: a Delphi consensus study. Lancet 2005, 366:2112-2117.
3. Slooter A.J., Tang M.X., van Duijn C.M., et al. Apolipoprotein E epsilon4 and the risk of dementia with stroke. a population-based investigation. JAMA 1997, 277:818-821.
4. Launer L.J., Masaki K., Petrovitch H., Foley D., Havlik R.J. The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study. JAMA 1995, 274:1846-1851.
5. Starr J.M., Whalley L.J., Inch S., Shering P.A. Blood pressure and cognitive function in healthy old people. J Am Geriatr Soc 1993, 41:753-756.
6. Qiu C., Winblad B., Fratiglioni L. The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol 2005, 4:487-499.
7. Messier C., Gagnon M. Glucose regulation and cognitive functions: relation to Alzheimer's disease and diabetes. Behav Brain Res 1996, 75:1-11.
8. Ott A., Stolk R.P., Hofman A., van Harskamp F., Grobbee D.E., Breteler M.M. Association of diabetes mellitus and dementia: the Rotterdam Study. Diabetologia 1996, 39:1392-1397.
9. Naderali E.K., Ratcliffe S.H., Dale M.C. Obesity and Alzheimer's disease: a link between body weight and cognitive function in old age. Am J Alzheimers Dis Other Demen 2009, 24:445-449.
10. Goldstein F.C., Ashley A.V., Endeshaw Y.W., Hanfelt J., Lah J.J., Levey A.I. Effects of hypertension and hypercholesterolemia on cognitive functioning in patients with Alzheimer disease. Alzheimer Dis Assoc Disord 2008, 22:336-342.
11. Kannel W.B. Risk factors for atherosclerotic cardiovascular outcomes in different arterial territories. J Cardiovasc Risk 1994, 1:333-339.
12. de la Torre J.C. Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics. Lancet Neurol 2004, 3:184-190.
13. Criqui M.H., Langer R.D., Fronek A., et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992, 6(326):381-386.
14. Haan M.N., Shemanski L., Jagust W.J., Manolio T.A., Kuller L. The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons. JAMA 1999, 282:40-46.
15. Price J.F., McDowell S., Whiteman M.C., Deary I.J., Stewart M.C., Fowkes F.G. Ankle brachial index as a predictor of cognitive impairment in the general population: ten-year follow-up of the Edinburgh Artery Study. J Am Geriatr Soc 2006, 54:763-769.
16. Johnson W., Price J.F., Rafnsson S.B., Deary I.J., Fowkes F.G. Ankle-brachial index predicts level of, but not change in, cognitive function: The Edinburgh Artery Study at the 15-year follow-up. Vasc Med 2010, 15:91-97.
17. Rafnsson S.B., Deary I.J., Fowkes F.G. Peripheral arterial disease and cognitive function. Vasc Med 2009, 14:51-61.
18. Fowkes F.G. The measurements of atherosclerotic peripheral disease in epidemiological surveys. Int J Epidemiol 1988, 17:248-254.
19. Woo J., Lynn H., Wong S.Y., et al. Correlates for a low ankle-brachial index in elderly Chinese. Atherosclerosis 2006, 186:360-366.
20. Breteler M.M., Claus J.J., Grobbee D.E., Hofman A. Cardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam Study. BMJ 1994, 308:1604-1608.
21. van Oijen M., de Jong F.J., Witteman J.C., Hofman A., Koudstaal P.J., Breteler M.M. Atherosclerosis and risk for dementia. Ann Neurol 2007, 61:403-410.
22. Laurin D., Masaki K.H., White L.R., Launer L.J. Ankle-to-brachial index and dementia: the Honolulu-Asia Aging Study. Circulation 2007, 116:2269-2274.
23. Hofman A., Ott A., Breteler M.M., et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet 1997, 349:151-154.
24. Newman A.B., Fitzpatrick A.L., Lopez O., et al. Dementia and Alzheimer's disease incidence in relationship to cardiovascular disease in the Cardiovascular Health Study cohort. J Am Geriatr Soc 2005, 53:1101-1107.
25. Sugawara N., Yasui-Furukori N., Umeda T., et al. Comparison of ankle-brachial pressure index and pulse wave velocity as markers of cognitive function in a community-dwelling population. BMC Psychiatry 2010, 10:46.
26. Vupputuri S., Shoham D.A., Hogan S.L., Kshirsagar A.V. Microalbuminuria, peripheral artery disease, and cognitive function. Kidney Int 2008, 73:341-346.
27. Bruce D.G., Davis W.A., Casey G.P., et al. Predictors of cognitive impairment and dementia in older people with diabetes. Diabetologia 2008, 51:241-248.
28. Mangiafico R.A., Sarnataro F., Mangiafico M., Fiore C.E. Impaired cognitive performance in asymptomatic peripheral arterial disease: relation to C-reactive protein and D-dimer levels. Age Ageing 2006, 35:60-65.
29. McDermott M.M., Greenland P., Guralnik J.M., et al. Depressive symptoms and lower extremity functioning in men and women with peripheral arterial disease. J Gen Intern Med 2003, 18:461-467.
30. Tiemeier H., van Dijck W., Hofman A., Witteman J.C., Stijnen T., Breteler M.M. Relationship between atherosclerosis and late-life depression: the Rotterdam Study. Arch Gen Psychiatry 2004, 61:369-376.
31. Dufouil C., Fuhrer R., Dartigues J.F., Alpérovitch A. Longitudinal analysis of the association between depressive symptomatology and cognitive deterioration. Am J Epidemiol 1996, 144:634-641.
32. Yaffe K., Blackwell T., Gore R., Sands L., Reus V., Browner W.S. Depressive symptoms and cognitive decline in nondemented elderly women: a prospective study. Arch Gen Psychiatry 1999, 56:425-430.
33. Jorm AF Is depression a risk factor for dementia or cognitive decline? A review. Gerontology 2000, 46:219-227.
34. Geerlings M.I., Schoevers R.A., Beekman A.T., et al. Depression and risk of cognitive decline and Alzheimer's disease. Results of two prospective community-based studies in The Netherlands. Br J Psychiatry 2000, 176:568-575.
35. Prince M., Jackson J. World Alzheimer Report 2009, Alzheimer's Disease International, London, http://www.alz.co.uk/research/files/World20Alzheimer%20Report.pdf (accessed 19.11.09).
36. Rao R., Jackson S., Howard R. Neuropsychological impairment in stroke, carotid stenosis, and peripheral vascular disease. A comparison with healthy community residents. Stroke 1999, 30:2167-2173.
37. Waldstein S.R., Tankard C.F., Maier K.J., et al. Peripheral arterial disease and cognitive function. Psychosom Med 2003, 65:757-763.
38. Singh-Manoux A., Britton A.R., Marmot M. Vascular disease and cognitive function: evidence from the Whitehall II Study. J Am Geriatr Soc 2003, 51:1445-1450.
39. Kuo H.K., Lin L.Y., Yu Y.H. Microalbuminuria is a negative correlate for cognitive function in older adults with peripheral arterial disease: results from the U.S. National Health and Nutrition Examination Survey 1999-2002. J Intern Med 2007, 262:562-570.
40. Muller M., Grobbee D.E., Aleman A., Bots M., van der Schouw Y.T. Cardiovascular disease and cognitive performance in middle-aged and elderly men. Atherosclerosis 2007, 190:143-149.
41. Honig L.S., Kukull W., Mayeux R. Atherosclerosis and AD: analysis of data from the US National Alzheimer's Coordinating Center. Neurology 2005, 64:494-500.
42. Bots M.L., van Swieten J.C., Breteler M.M., et al. Cerebral white matter lesions and atherosclerosis in the Rotterdam Study. Lancet 1993, 341:1232-1237.
43. Swan G.E., DeCarli C., Miller B.L., Reed T., Wolf P.A., Carmelli D. Biobehavioral characteristics of nondemented older adults with subclinical brain atrophy. Neurology 2000, 54:2108-2114.